-
-
-
-
-
-
-
Form SCHEDULE 13G/A VERACYTE, INC. Filed by: ARK Investment Management LLC
-
-
-
-
-
-
-
Veracyte biomarker predicts hormone therapy benefit in prostate cancer
-
-
-
-
-
-
-
Veracyte (VCYT) added to S&P 600
-
-
-
-
-
-
-
Veracyte (VCYT) Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer
-
-
-
-
-
-
-
Form SCHEDULE 13G/A VERACYTE, INC. Filed by: ARK Investment Management LLC
-
-
-
-
-
-
-
Veracyte, Inc (VCYT) PT Raised to $40 at Scotiabank
-
-
-
-
-
-
-
Form SC 13G/A VERACYTE, INC. Filed by: ARK Investment Management LLC
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

